title: [Medical treatment of Raynaud's syndrome].
abstract: The authors review the drug treatment of Raynaud's disease. Many substances have been used including nitrate derivatives, calcium antagonists, alpha blockers, angiotensin converting enzyme inhibitors, prostaglandin E1, E2 and I2, and ketanserin. The efficacy of these drugs is often partial and variable. The indications are discussed with respect to the clinical course and etiology of the Raynaud's phenomenon.
authors.affiliation: Clinique dermatologique, hôpital E. Herriot, Lyon.
authors.forename: J P
authors.initials: JP
authors.lastname: Larbre
authors.forename: J F
authors.initials: JF
authors.lastname: Nicolas
authors.forename: B
authors.initials: B
authors.lastname: Larbre
authors.forename: P
authors.initials: P
authors.lastname: Perret-Liaudet
authors.forename: C
authors.initials: C
authors.lastname: Adam
authors.forename: J
authors.initials: J
authors.lastname: Thivolet
mesh_terms: D003240:Connective Tissue Diseases / Q000150:complications*; D006801:Humans; D011928:Raynaud Disease / Q000188:drug therapy* / Q000209:etiology
vernacular_title: Le traitement médical du syndrome de Raynaud.